Christopher M. Harris

Author

AbbVie (United States)ORCID

Also Known As

C Harris, C M Harris, C. Harris, C. M. Harris, Christopher M Harris, Christopher M. Harris, Conrad M Harris

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)University of Leeds University of Michigan Abbott Fund University College London

About

Christopher M. Harris is an author at AbbVie (United States) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	402
2	Biochemistry	7	7	276
3	Natural Sciences	6	6	265
4	Engineering	1	1	11
5	Anatomy	1	1	19

Christopher M. Harris

Publications

881

Citations

H-Index

Page 1

	Year	Citations
Fundholders' prescribing costs: the first five years Christopher M. Harris, G. Scrivener BMJ	1996	97
Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol Eric R. Goedken, M.A. Argiriadi, David Banach, Journal of Biological Chemistry	2015	96
The Reaction of Reduced Xanthine Dehydrogenase with Molecular Oxygen Christopher M. Harris, Vincent Massey Journal of Biological Chemistry Animal PhysiologyChemical BiologyXanthine/oxygen Turnover AssaysAldehyde DehydrogenaseBiochemistry	1997	94
pH and kinetic isotope effects in <scp>d</scp>‐amino acid oxidase catalysis. Christopher M. Harris, Loredano Pollegioni, Sandro Ghisla European Journal of Biochemistry Chemical KineticsSolvent IsotopeAlcohol DehydrogenasesBiochemistryAldehyde Dehydrogenase	2001	70
The Oxidative Half-reaction of Xanthine Dehydrogenase with NAD; Reaction Kinetics and Steady-state Mechanism Christopher M. Harris, Vincent Massey Journal of Biological Chemistry	1997	62
Joubert syndrome: long‐term follow‐up P R Hodgkins, Christopher M. Harris, Fatima Shawkat, Developmental Medicine & Child Neurology Joubert SyndromeNeurological DisorderPathologyNeurologyAbnormal Development	2004	60
Low income scheme index: a new deprivation scale based on prescribing in general practice D. C. Lloyd, Christopher M. Harris, D. W Clucas BMJ	1995	49
Role of the Flavin Midpoint Potential and NAD Binding in Determining NAD Versus Oxygen Reactivity of Xanthine Oxidoreductase Christopher M. Harris, Stephen A. Sanders, Vincent Massey Journal of Biological Chemistry Chemical BiologyFlavin Midpoint PotentialBiochemistryNatural SciencesEnzyme Catalysis	1999	49
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P<sub>5</sub>) Agonist for the Potential Treatment of Neurodegenerative Disorders Adrian D. Hobson, Christopher M. Harris, Elizabeth L. van der Kam, Journal of Medicinal Chemistry Cell DeathExperimental PharmacologySynaptic SignalingLipid AccumulationCompound 29	2015	47
ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation Christian Goess, Christopher M. Harris, Sara Murdock, Modern Rheumatology	2018	37

Page 1